Utility of Postoperative Circulating Tumor DNA (ctDNA) as a Prognostic Marker of Disease Recurrence in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis

被引:0
|
作者
Alqahtani, Ali [1 ]
Ghazaleh, Sami [2 ]
Albalawy, Rakan [2 ]
Abdulsattar, Waleed [2 ]
Cook, Michael [3 ]
Lee-Smith, Wade [4 ]
Aziz, Muhammad [2 ]
Alhallak, Mohammed Najeeb [5 ]
机构
[1] Georgetown Univ, Arlington, VA USA
[2] Univ Toledo, Med Ctr, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Georgetown Univ, Washington, DC USA
[4] Univ Toledo, 2801 W Bancroft St, Toledo, OH 43606 USA
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S0333
引用
收藏
页码:S163 / S163
页数:1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
    Tie, Jeanne
    Kinde, Isaac
    Wang, Yuxuan
    Wong, Hui-li
    Skinner, Iain
    Wong, Rachel
    Steel, Malcolm
    Diaz, Luis A.
    Papadopoulos, Nickolas
    Kosmider, Suzanne
    Yip, Desmond
    Underhill, Craig
    Haydon, Andrew Mark
    Christie, Michael
    Strausberg, Robert
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Prognostic utility of preoperative and postoperative circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Alqahtani, Ali
    Alloghbi, Abdurahman
    Yin, Chao
    Mukherji, Reetu
    Weinberg, Benjamin Adam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [3] Circulating tumor DNA as a prognostic indicator of colorectal cancer recurrence—a systematic review and meta-analysis
    Yikuan Chen
    Shaobo Mo
    Mengdi Wu
    Yaqi Li
    Xi Chen
    Junjie Peng
    [J]. International Journal of Colorectal Disease, 2022, 37 : 1021 - 1027
  • [4] Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer Reply
    Tie, Jeanne
    Vogelstein, Bert
    Gibbs, Peter
    [J]. JAMA ONCOLOGY, 2020, 6 (06) : 932 - 933
  • [5] Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Alqahtani, Ali
    Alloghbi, Abdurahman
    Coffin, Philip
    Yin, Chao
    Mukherji, Reetu
    Weinberg, Benjamin A.
    [J]. SURGICAL ONCOLOGY-OXFORD, 2023, 51
  • [6] Circulating tumor DNA as a prognostic indicator of colorectal cancer recurrence-a systematic review and meta-analysis
    Chen, Yikuan
    Mo, Shaobo
    Wu, Mengdi
    Li, Yaqi
    Chen, Xi
    Peng, Junjie
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (05) : 1021 - 1027
  • [7] Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
    Bockelman, Camilla
    Engelmann, Bodil E.
    Kaprio, Tuomas
    Hansen, Torben F.
    Glimelius, Bengt
    [J]. ACTA ONCOLOGICA, 2015, 54 (01) : 5 - 16
  • [8] Circulating tumor DNA detection as a prognostic tool in patients with localized colon cancer: A systematic review and meta-analysis
    Do, Quan
    Katiyar, Vatsala
    Malloy, Meghan
    Sharma, Vivek R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer.
    Wang, Judy Sing-Zan
    Sausen, Mark
    Parpart-Li, Sonya
    Murphy, Derek M.
    Velculescu, Victor E.
    Wood, Laura D.
    Solt-Linville, Sara
    Sugar, Elizabeth
    Bartlett, Bjarne
    Blair, Cherie
    Dauses, Tianna
    Jaffee, Elizabeth M.
    Hruban, Ralph H.
    Laheru, Dan
    Diaz, Luis A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
    Guven, Deniz Can
    Sahin, Taha Koray
    Yildirim, Hasan Cagri
    Aktepe, Oktay Halit
    Dizdar, Omer
    Yalcin, Suayib
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168